PDL1 expression predicted the complete pathological response to neoadjuvant chemotherapy was higher in IBC patients than on non-IBC patients, correlated with T-lymphocyte infiltration in the tumor [161]. Here, CD274 is linked to inflammatory breast carcinoma.